New Partnership between Marubeni/Clairvo and Perspectum to bring LiverMultiScan to Japan
May 26, 2021
Perspectum Partners in a New Study in Singapore for the Early Detection of Liver Cancer using Precision Medicine
May 4, 2021
New Study Shows Measurable Organ Impairment in Long COVID Patients
April 26, 2021
Perspectum Appoints Annalisa Jenkins, MBBS, FRCP to Board of Directors
April 22, 2021
High Liver Fat (Hepatic Steatosis) Linked to Increased Risk of Hospitalization in COVID-19 Patients with Obesity
March 29, 2021
LiverMultiScan shown to be the best non-invasive predictor of disease activity in autoimmune hepatitis, demonstrating its potential to influence clinical treatment.
March 3, 2021
Perspectum Lands Top Spot in Alantra Pharma Fast 50 Rankings
March 1, 2021
New research demonstrates superior performance of LiverMultiScan® for identifying patients with NASH and fibrosis
February 24, 2021
LiverMultiScan® could be an alternative to liver biopsy for NASH clinical trials.
February 4, 2021
